Quantum Computing, Inc. is focused on providing tools and software applications for quantum computers. The company is headquartered in Leesburg, Virginia.
| Revenue (TTM) | $9.82M |
| Gross Profit (TTM) | $-1.86M |
| EBITDA | $-61.12M |
| Operating Margin | -281.30% |
| Return on Equity | -1.51% |
| Return on Assets | -4.16% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $7.03 |
| Price-to-Book | 0.80 |
| Price-to-Sales (TTM) | 145.84 |
| EV/Revenue | 34.74 |
| EV/EBITDA | -3.73 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 9000.00% |
| Shares Outstanding | $226.35M |
| Float | $200.64M |
| % Insiders | 12.16% |
| % Institutions | 48.79% |
Volatility is currently expanding
QUBT heads into its Nov. 9 earnings report with a $42.5 million backlog, strategic buyouts and $1.3 billion in cash, but rising costs and losses are concerns.
IonQ's trapped ion technology could disrupt older systems. D-Wave's quantum-powered “efficiency expert” tools are gaining momentum.
Government support will be a major swing factor, and several of these companies are counting on funding agreements that have not yet closed. The quantum technology field is getting crowded fast, and companies' valuations are running far ahead of the revenue they actually book.
HOBOKEN, N.J., Oct. 26, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), a vertically integrated quantum company pioneering photonics and semiconductor manufacturing, today announced that the Company will host a conference call and webcast on Monday, November 9, 2026 at 4:30 p.m.
Next to the artificial intelligence infrastructure build-out, no trend is capturing the attention of investors quite like the evolution of quantum computing. Form 4 filings show that quantum computing insiders have been decisive sellers of their company's stock over the last half-decade.
Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development BOCA RATON, Fla. and HOBOKEN, N.J.
Quantinuum, backed by Honeywell's continued majority-voting stake, is still working through post-IPO price discovery following its June Nasdaq debut. IBM's quantum bet is funded by its much larger, profitable core business, giving it a longer runway than smaller pure-play competitors.
Scales quantum optimization to up to nearly 10,000 variables, a 10x increase over QCi's current 1,000-variable system, while delivering faster performance, production-ready reliability and scalable manufacturing First customer shipment of Dirac-3S upgrade expected in Q4 2026 HOBOKEN, N.J., Oct. 1, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), a vertically integrated quantum systems company pioneering photonics and semiconductor manufacturing, today announced Dirac-3S, the next-generation of its Dirac-3 quantum optimization machine, marking a significant step toward commercial deployment of QCi's quantum optimization technology.
QUBT pairs surging revenues, photonics expansion and a $42.5M backlog with analyst targets implying more upside than Rigetti, though execution risks remain.
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT) breached their fiduciary duties to shareholders.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on QUBT and any ticker you trade — then tracks every position and per-strategy win rate.
